loadpatents
name:-0.05124306678772
name:-0.036799907684326
name:-0.0051980018615723
Matsushima; Kouji Patent Filings

Matsushima; Kouji

Patent Applications and Registrations

Patent applications and USPTO patent grants for Matsushima; Kouji.The latest application filed is for "analgesic agent and sedative agent".

Company Profile
5.35.41
  • Matsushima; Kouji - Tokyo JP
  • Matsushima; Kouji - Bunkyo-ku JP
  • Matsushima; Kouji - Chiba JP
  • Matsushima; Kouji - Matsudo JP
  • MATSUSHIMA; Kouji - Matsudo-shi JP
  • Matsushima, Kouji - Frederick MD
  • Matsushima, Kouji - Kanazawa-shi JP
  • Matsushima; Kouji - Kanazawa JP
  • Matsushima; Kouji - Ishikawa JP
  • Matsushima; Kouji - Ishikawa Prefecture JP
  • Matsushima; Kouji - Kawasaki JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for predicting prognosis of patient with cancer or inflammatory disease
Grant 11,193,172 - Terashima , et al. December 7, 2
2021-12-07
Method for reducing side effects of immune checkpoint control agent
Grant 11,168,137 - Ito , et al. November 9, 2
2021-11-09
Analgesic Agent And Sedative Agent
App 20210220320 - TERASHIMA; Yuya ;   et al.
2021-07-22
Hmgn Partial Peptide And Cancer Therapy Using The Same
App 20200407408 - MATSUSHIMA; Kouji ;   et al.
2020-12-31
Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient
Grant 10,746,726 - Matsushima , et al. A
2020-08-18
Agent For Controlling Cells Constituting Cancer Microenvironment Or Inflammatory Microenvironment
App 20200253896 - Kind Code
2020-08-13
Method for analyzing nucleic acid derived from single cell
Grant 10,738,352 - Hashimoto , et al. A
2020-08-11
Agent for controlling cells constituting cancer microenvironment or inflammatory microenvironment
Grant 10,722,480 - Terashima , et al.
2020-07-28
Methods and compositions for modulating immune tolerance
Grant 10,300,115 - Biragyn , et al.
2019-05-28
Therapeutic Agent For Solid Cancer
App 20190125867 - ITO; Satoru ;   et al.
2019-05-02
Method For Predicting Prognosis Of Patient With Cancer Or Inflammatory Disease
App 20180237860 - TERASHIMA; Yuya ;   et al.
2018-08-23
Prophylactic and/or therapeutic agent for radiation damage
Grant 9,895,331 - Tanaka , et al. February 20, 2
2018-02-20
Agent For Controlling Cells Constituting Cancer Microenvironment Or Inflammatory Microenvironment
App 20180000755 - TERASHIMA; Yuya ;   et al.
2018-01-04
Method For Assessing Therapeutic Effect Of Anti-cancer Agent Having Anti-cd4 Antibody As Active Ingredient
App 20170328887 - MATSUSHIMA; Kouji ;   et al.
2017-11-16
Method For Analyzing Nucleic Acid Derived From Single Cell
App 20170166959 - Hashimoto; Shin-ichi ;   et al.
2017-06-15
Therapeutic Agent For Solid Cancer
App 20170165364 - ITO; Satoru ;   et al.
2017-06-15
Method For Reducing Side Effects Of Immune Checkpoint Control Agent
App 20170145099 - ITO; Satoru ;   et al.
2017-05-25
Methods And Compositions For Modulating Immune Tolerance
App 20170119858 - Biragyn; Arya ;   et al.
2017-05-04
Methods and compositions for modulating immune tolerance
Grant 9,605,044 - Biragyn , et al. March 28, 2
2017-03-28
Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect
Grant 9,156,912 - Matsushima , et al. October 13, 2
2015-10-13
Prophylactic And/or Therapeutic Agent For Radiation Damage
App 20150190356 - Tanaka; Tohru ;   et al.
2015-07-09
Proteins expressed in NK cells
Grant 8,946,386 - Matsushima , et al. February 3, 2
2015-02-03
Methods and Compositions for Modulating Immune Tolerance
App 20140341937 - Biragyn; Arya ;   et al.
2014-11-20
Methods and compositions for modulating immune tolerance
Grant 8,795,674 - Biragyn , et al. August 5, 2
2014-08-05
Immunological Reconstitution Promoter Or Prophylactic Agent For Infections Each Of Which Maintains Graft-versus-tumor Effect
App 20120027748 - Matsushima; Kouji ;   et al.
2012-02-02
Methods and Compositions for Modulating Immune Tolerance
App 20110081370 - Biragyn; Arya ;   et al.
2011-04-07
Molecule associating with intracellular C-terminal domain of receptor
Grant 7,759,066 - Matsushima , et al. July 20, 2
2010-07-20
Method For Promoting Immunotherapy Using An Agent For Elevating Dendritic Cell Precursor Level In Blood
App 20100021442 - MATSUSHIMA; Kouji ;   et al.
2010-01-28
Recombinant virus and use thereof
App 20090214587 - Kohara; Michinori ;   et al.
2009-08-27
Methods for Obtaining Gene Tags
App 20090117538 - Hashimoto; Shin-ichi ;   et al.
2009-05-07
Molecule Associating With Intracellular C-terminal Domain Of Receptor
App 20090081693 - MATSUSHIMA; Kouji ;   et al.
2009-03-26
Method for promoting immunotherapy
App 20080124307 - Matsushima; Kouji ;   et al.
2008-05-29
Antagonists of MCP-1 function and methods of use thereof
Grant 7,297,696 - Laborde , et al. November 20, 2
2007-11-20
Proteins Expressed In Ink Cells
App 20070202501 - Matsushima; Kouji ;   et al.
2007-08-30
Remedy for sarcoidosis and method of treating the same
App 20070111956 - Matsushima; Kouji ;   et al.
2007-05-17
Prevention and treatment for GVHD
App 20060233710 - Matsushima; Kouji ;   et al.
2006-10-19
Agent eleveting dendritic cell precursor level in blood
App 20060210531 - Matsushima; Kouji ;   et al.
2006-09-21
Antagonists of MCP-1 function and methods of use thereof
Grant 6,998,407 - Laborde , et al. February 14, 2
2006-02-14
Antagonists of MCP-1 function and methods of use thereof
Grant 6,992,086 - Laborde , et al. January 31, 2
2006-01-31
Molecules associating to c-terminal domain in receptor cell
App 20060008801 - Matsushima; Kouji ;   et al.
2006-01-12
Antagonist of MCP-1 function, and compositions and methods of use thereof
Grant 6,962,926 - Laborde , et al. November 8, 2
2005-11-08
Antagonists of MCP-1 function and methods of use thereof
App 20050054668 - Laborde, Edgardo ;   et al.
2005-03-10
Antagonists of MCP-1 function and methods of use thereof
Grant 6,809,113 - Laborde , et al. October 26, 2
2004-10-26
Antagonist of MCP-1 function, and compositions and methods of use thereof
App 20040198719 - Laborde, Edgardo ;   et al.
2004-10-07
Antagonists of MCP-1 function and methods of use thereof
App 20040127513 - Laborde, Edgardo ;   et al.
2004-07-01
Antagonists of MCP-1 function and methods of use thereof
App 20040077680 - Laborde, Edgardo ;   et al.
2004-04-22
Antagonists of MCP-1 function and methods of use thereof
Grant 6,677,365 - Laborde , et al. January 13, 2
2004-01-13
Antagonists of MCP-1 function and methods of use thereof
Grant 6,670,364 - Laborde , et al. December 30, 2
2003-12-30
Antagonists of MCP-1 function and methods of use thereof
App 20030105085 - Laborde, Edgardo ;   et al.
2003-06-05
Antagonists of MCP-1 function and methods of use thereof
App 20030096705 - Laborde, Edgardo ;   et al.
2003-05-22
Antagonists of MCP-1 function and methods of use thereof
App 20030092728 - Laborde, Edgardo ;   et al.
2003-05-15
Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein
App 20030032168 - Hirose, Kunitaka ;   et al.
2003-02-13
Sepsis remedy comprising anti-IL-8 antibody as active ingredient
App 20030021783 - Kitajima, Masaki ;   et al.
2003-01-30
Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein
App 20030022352 - Hirose, Kunitaka ;   et al.
2003-01-30
Novel neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto
App 20020151706 - Matsushima, Kouji ;   et al.
2002-10-17
Therapeutic Agent For Acute Lung Injury Resulting From Indirect Causes Comprising Anti-il-8 Antibody As Active Ingredient
App 20020141988 - MATSUSHIMA, KOUJI ;   et al.
2002-10-03
Human Adamts-1 Protein, Gene Coding The Same, Pharmaceutical Composition, And Method For Immunologically Assaying Human Adamts-1 Protein
App 20020119167 - HIROSE, KUNITAKA ;   et al.
2002-08-29
Reshaped human antibody to human interleukin-8
App 20020082396 - Matsushima, Kouji ;   et al.
2002-06-27
Nucleic acids encoding a novel neutrophil chemotactic factor
Grant 6,376,659 - Matsushima , et al. April 23, 2
2002-04-23
Sepsis Remedy Comprising Anti-il-8 Antibody As Active Ingredient
App 20020006405 - KITAJIMA, MASAKI ;   et al.
2002-01-17
Rheumatoid Arthritis Remedy Containing Anti-il-8 Antibody As Active Ingredient
App 20010006637 - AKAHOSHI, TOHRU ;   et al.
2001-07-05
Reshaped human antibody to human interleukin-8
Grant 6,245,894 - Matsushima , et al. June 12, 2
2001-06-12
Method to treat inflammation with humanized anti-IL-8-antibodies
Grant 6,024,956 - Matsushima , et al. February 15, 2
2000-02-15
Polynucleotides which encode reshaped IL-8-specific antibodies and methods to produce the same
Grant 5,994,524 - Matsushima , et al. November 30, 1
1999-11-30
Peptide suppressing I.kappa.B.alpha. phosphorylation
Grant 5,981,486 - Matsushima , et al. November 9, 1
1999-11-09
Method of treating inflammation with antibodies to neutrophil chemotactic factor
Grant 5,925,352 - Matsushima , et al. July 20, 1
1999-07-20
Supression of nephritis-induced protein excretion by anti-IL-8
Grant 5,707,621 - Matsushima January 13, 1
1998-01-13
Antibodies specific for neutrophic chemotactic factor
Grant 5,698,196 - Matsushima , et al. December 16, 1
1997-12-16
Neutrophil chemotactic factor
Grant 5,652,338 - Matsushima , et al. July 29, 1
1997-07-29
Therapeutic agent for treating wounds using monocyte chemotactic and activating factor
Grant 5,646,117 - Matsushima , et al. July 8, 1
1997-07-08
Method of preparing an active human neutrophil chemotactic factor polypeptide
Grant 5,401,643 - Yamada , et al. * March 28, 1
1995-03-28
Process for producing a human neutrophil chemotactic factor peptide and a recombinant expression vector for the said polypeptide
Grant 5,306,627 - Yamada , et al. April 26, 1
1994-04-26
Cordless telephone communication system
Grant 4,930,149 - Matsushima May 29, 1
1990-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed